RBS2418 / Riboscience 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
RBS2418 / Riboscience
NCT05270213: Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors

Recruiting
1
64
US
RBS2418, Pembrolizumab
Riboscience, LLC., Oncobay Clinical, Inc
Advanced Cancer
09/25
10/25
NCT05683470: Expanded Access RBS2418 Treatment

No Longer Available
N/A
NA
RBS2418
Riboscience, LLC., Dr. Bertrand Tuan
Expanded Access in Pancreatic Cancer
 
 

Download Options